WEC
XTNT icon

Winslow Evans & Crocker’s Xtant Medical Holdings XTNT Stock Holding History

Winslow Evans & Crocker’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2K Hold
1,258
– – ﹤0.01% 1252
2020
Q3 		$1K Hold
1,258
– – ﹤0.01% 1072
2020
Q2 		$1K Hold
1,258
– – ﹤0.01% 1114
2020
Q1 		$2K Hold
1,258
– – ﹤0.01% 1087
2019
Q4 		$4K Hold
1,258
– – ﹤0.01% 1046
2019
Q3 		$4K Hold
1,258
– – ﹤0.01% 1039
2019
Q2 		$4K Hold
1,258
– – ﹤0.01% 1035
2019
Q1 		$4K Hold
1,258
– – ﹤0.01% 1065
2018
Q4 		$4K Hold
1,258
– – ﹤0.01% 978
2018
Q3 		$6K Hold
1,258
– – ﹤0.01% 927
2018
Q2 		$8K Hold
1,258
– – ﹤0.01% 866
2018
Q1 		$9.93K Sell
1,258
-1
-0.1% -$7 ﹤0.01% 794
2017
Q4 		$8.65K Hold
1,259
– – ﹤0.01% 837
2017
Q3 		$10.9K Hold
1,259
– – ﹤0.01% 804
2017
Q2 		$9.97K Hold
1,259
– – ﹤0.01% 916
2017
Q1 		$9.41K Hold
1,259
– – ﹤0.01% 902
2016
Q4 		$8.31K Hold
1,259
– – ﹤0.01% 924
2016
Q3 		$17.1K Hold
1,259
– – ﹤0.01% 772
2016
Q2 		$28.9K Hold
1,259
– – 0.01% 625
2016
Q1 		$41K Hold
1,259
– – 0.01% 547
2015
Q4 		$42.3K Buy
+1,259
New +$44.2K 0.01% 568

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Winslow Evans & Crocker's XTNT Position: Q4 2020 in Review

Winslow Evans & Crocker held its Xtant Medical Holdings (XTNT) position steady in Q4 2020 at 1,258 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Winslow Evans & Crocker first reported a position in XTNT in Q4 2015 and has held it in 21 quarters since. The position peaked at $42.3K in Q4 2015. 20 funds tracked by Wall St. Rank hold XTNT as of Q4 2020.

  • Winslow Evans & Crocker held 1,258 shares of Xtant Medical Holdings worth $2K as of Q4 2020.
  • Winslow Evans & Crocker left its Xtant Medical Holdings share count unchanged in Q4 2020.
  • Xtant Medical Holdings made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1252 holding.
  • Winslow Evans & Crocker first reported a position in Xtant Medical Holdings in Q4 2015 and has held it in 21 quarters since.
  • Winslow Evans & Crocker's Xtant Medical Holdings position peaked at $42.3K in Q4 2015.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.